Abstract
Software and hardware innovations, smart devices, digitization in healthcare, IoT (Internet of Things), and other emerging device technologies are driving the medical device industry as one of the fastest growing markets around the globe. Medical devices carry some measure of risk that can potentially cause problems or result in harm impacting patient safety significantly. The challenge manufacturers face is obtaining government marketing authorization for the proposed new medical device before it can be legally sold in its respective jurisdiction. This chapter examines key regulatory aspects and the importance of the use of standards and their increasing importance as a regulatory tool in medical device regulation. Five countries or regions with advanced medical device regulatory systems were explored: the USA, European Union (EU), Canada, Australia, and Japan.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
The information provided here is based on information available online (accessed: May 1, 2019) https://www.tga.gov.au/publication/australian-regulatory-guidelines-medical-devices-argmd
- 2.
The sponsor obtains the classification and GMDN (Global Medical Device Nomenclature) codes from the manufacturer. GMDN is a list of internationally agreed generic names/descriptors used to identify all medical device products and managed by the GMDN Agency.
- 3.
Organization Chart, MHLW https://www.mhlw.go.jp/english/org/detail/dl/organigram.pdf
- 4.
Be aware that the term Registration carry a different meaning in the US system. It is associated with Establishment Registration and Device Listing; which is done only after the device has obtained FDA market clearance or approval.
- 5.
GHTF archived documents are accessible at the IMDRF site, http://www.imdrf.org/ghtf/ghtf-archives-sg1.asp
- 6.
- 7.
- 8.
- 9.
- 10.
References
ASEAN Medical Device Directive. 2015 [Online]. https://asean.org/wp-content/uploads/2016/06/22.-September-2015-ASEAN-Medical-Device Directive.pdf.
Study Group 1 of the Global Harmonization Task Force (GHTF). Definition of the terms ‘Medical Device’ and ‘In Vitro Diagnostic (IVD) Medical Device’. GHTF Final Document (revision of GHTF/SG1/N29:2005). 2012. [Online]. http://www.imdrf.org/docs/ghtf/final/sg1/technical-docs/ghtf-sg1-n071-2012-definition-of-terms-120516.pdf.
U.S. Code of Federal Regulations (CFR) [Online]. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPartFrom=800&CFRPartTo=1299.
Public Law 94-295 94th Congress, Medical Device Amendments of 1976, amend the Federal, Food, Drug, and Cosmetic Act, 28 May 1976.
Legislative Act, Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017.
European Commission. Guidance document, classification of medical devices. Annex IX of Council Directive 93/42/EEC, MEDDEV 2.4/1 rev.9, June 2010.
Canadian Medical Devices Regulations (CMDR) SOR/98-282, last amended March 4, 2019. Current to March 27, 2019.
Minister or Health, Government of Canada. Guidance on the risk-based classification system for non-In Vitro Diagnostic Devices (non-IVDDs). Effective date, June 12, 2015.
Therapeutic Goods (Medical Device Regulations 2002. Compilation No. 39), latest compilation date is December 1, 2018.
Australian Therapeutics Goods Administration Health Safety Regulation. Use of market authorisation evidence from comparable overseas regulators/assessment bodies for medical devices (including IVDs). Ver 1.1, Nov 2018.
Regulatory Information Task Force, Japanese Pharmaceutical Manufacturers Association. Pharmaceutical administration and regulations in Japan; 2017.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Carey, C.C. (2019). Key Regulatory Aspects and the Importance of Consensus Standards in Bringing Devices to Market. In: Solà, J., Delgado-Gonzalo, R. (eds) The Handbook of Cuffless Blood Pressure Monitoring. Springer, Cham. https://doi.org/10.1007/978-3-030-24701-0_11
Download citation
DOI: https://doi.org/10.1007/978-3-030-24701-0_11
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-24700-3
Online ISBN: 978-3-030-24701-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)